Advertisement

Metoprolol Versus Carvedilol in Patients With Heart Failure, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, and Renal Failure

Published:January 09, 2020DOI:https://doi.org/10.1016/j.amjcard.2019.12.048
      This study compared the survival and the risk of heart failure (HF), chronic obstructive pulmonary disease (COPD), diabetes mellitus (DM), hypoglycemia, and renal failure (RF) hospitalizations in geriatric patients exposed to carvedilol or metoprolol. Data sources were Danish administrative registers. Patients aged ≥65 and having HF, COPD, and DM were followed for 1 year from the first β-blocker prescription redemption. Patients' characteristics were used to 1:1 propensity score match carvedilol and metoprolol users. A Cox regression model was used to compute the hazard ratio (HR) of study outcomes. For statistically significant associations, a conditional inference tree was used to assess predictors most associated with the outcome. In total, 1,424 patients were included. No statistically significant differences were observed for survival (HR 0.86; 95% confidence interval [CI] 0.67 to 1.11, p = 0.240) between carvedilol/metoprolol users. The same applied to COPD (HR 0.88; 95% CI 0.75 to 1.05, p = 0.177), DM (HR 0.95; 95% CI 0.82 to 1.10, p = 0.485), hypoglycemia (HR 0.88; 95% CI 0.47 to 1.67, p = 0.707), and RF (HR 1.25; 95% CI 0.93 to 1.69, p = 0.142) hospitalizations. Carvedilol users had a 38% higher hazard then metoprolol users of HF hospitalization during the follow-up period (HR 1.38; 95% CI 1.19 to 1.60, p <0.001). Artificial intelligence identified carvedilol exposure as the most important predictor for HF hospitalization. In conclusion, we found an increased risk of HF hospitalization for carvedilol users with this triad of diseases but no statistically significant differences in survival or risk of COPD, DM, hypoglycemia, and RF hospitalizations.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kotecha D
        • Flather MD
        • Altman DG
        • Holmes J
        • Rosano G
        • Wikstrand J
        • Packer M
        • Coats AJS
        • Manzano L
        • Bohm M
        • Veldhuisen DJ van
        • Andersson B
        • Wedel H
        • Lueder TG von
        • Rigby AS
        • Hjalmarson A
        • Kjekshus J
        • Cleland JGF
        Heart rate and rhythm and the benefit of beta-blockers in patients with heart failure.
        J Am Coll Cardiol. 2017; 69: 2885-2896
        • Ponikowski P
        • Voors AA
        • Anker SD
        • Bueno H
        • Cleland JGF
        • Coats AJS
        • Falk V
        • Gonzalez-Juanatey JR
        • Harjola V-P
        • Jankowska EA
        • Jessup M
        • Linde C
        • Nihoyannopoulos P
        • Parissis JT
        • Pieske B
        • Riley JP
        • Rosano GMC
        • Ruilope LM
        • Ruschitzka F
        • Rutten FH
        • Meer P van der
        2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.
        Rev Esp Cardiol (Engl Ed). 2016; 69: 1167
        • Yancy CW
        • Jessup M
        • Bozkurt B
        • Butler J
        • Casey DEJ
        • Colvin MM
        • Drazner MH
        • Filippatos GS
        • Fonarow GC
        • Givertz MM
        • Hollenberg SM
        • Lindenfeld J
        • Masoudi FA
        • McBride PE
        • Peterson PN
        • Stevenson LW
        • Westlake C
        2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of Amer.
        J Card Fail. 2017; 23: 628-651
        • Al-Mohammad A
        • Mant J
        • Laramee P
        • Swain S
        Diagnosis and management of adults with chronic heart failure: summary of updated NICE guidance.
        BMJ. 2010; 341: c4130
        • Ezekowitz JA
        • O'Meara E
        • McDonald MA
        • Abrams H
        • Chan M
        • Ducharme A
        • Giannetti N
        • Grzeslo A
        • Hamilton PG
        • Heckman GA
        • Howlett JG
        • Koshman SL
        • Lepage S
        • McKelvie RS
        • Moe GW
        • Rajda M
        • Swiggum E
        • Virani SA
        • Zieroth S
        • Al-Hesayen A
        • Cohen-Solal A
        • D'Astous M
        • De S
        • Estrella-Holder E
        • Fremes S
        • Green L
        • Haddad H
        • Harkness K
        • Hernandez AF
        • Kouz S
        • LeBlanc M-H
        • Masoudi FA
        • Ross HJ
        • Roussin A
        • Sussex B
        2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure.
        Can J Cardiol. 2017; 33: 1342-1433
        • Atherton JJ
        • Sindone A
        • Pasquale CG De
        • Driscoll A
        • MacDonald PS
        • Hopper I
        • Kistler PM
        • Briffa T
        • Wong J
        • Abhayaratna W
        • Thomas L
        • Audehm R
        • Newton P
        • O'Loughlin J
        • Branagan M
        • Connell C
        National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: guidelines for the prevention, detection, and management of heart failure in Australia 2018.
        Heart Lung Circ. 2018; 27: 1123-1208
        • Sessa M
        • Mascolo A
        • Rasmussen DB
        • Kragholm K
        • Jensen MT
        • Sportiello L
        • Rafaniello C
        • Tari GM
        • Pagliaro C
        • Andersen M
        • Rossi F
        • Capuano A
        Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study.
        Sci Rep. 2019; 9: 11465
        • Saczynski JS
        • Darling CE
        • Spencer FA
        • Lessard D
        • Gore JM
        • Goldberg RJ
        Clinical features, treatment practices, and hospital and long-term outcomes of older patients hospitalized with decompensated heart failure: the Worcester heart failure study.
        J Am Geriatr Soc. 2009; 57: 1587-1594
        • Bakris GL
        • Fonseca V
        • Katholi RE
        • McGill JB
        • Messerli FH
        • Phillips RA
        • Raskin P
        • Wright JTJ
        • Oakes R
        • Lukas MA
        • Anderson KM
        • Bell DSH
        Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
        JAMA. 2004; 292: 2227-2236
        • Ho T-W
        • Huang C-T
        • Ruan S-Y
        • Tsai Y-J
        • Lai F
        • Yu C-J
        Diabetes mellitus in patients with chronic obstructive pulmonary disease-the impact on mortality.
        PLoS One. 2017; 12 (e0175794–e0175794. Available at:)
        • Lehrke M
        • Marx N
        Diabetes mellitus and heart failure.
        Am J Med. 2017; 130: S40-S50
        • Garvin JH
        • Redd A
        • Bolton D
        • Graham P
        • Roche D
        • Groeneveld P
        • Leecaster M
        • Shen S
        • Weiner MG
        Exploration of ICD-9-CM coding of chronic disease within the elixhauser comorbidity measure in patients with chronic heart failure.
        Perspect Heal Inf Manag. 2013; 10: 1b
        • Patorno E
        • Glynn RJ
        • Hernandez-Diaz S
        • Liu J
        • Schneeweiss S
        Studies with many covariates and few outcomes: selecting covariates and implementing propensity-score-based confounding adjustments.
        Epidemiology. 2014; 25: 268-278
        • Gray RJ
        A class of K-sample tests for comparing the cumulative incidence of a competing risk.
        Ann Stat. 1988; : 1141-1154
        • Hothorn T
        • Hornik K
        • Zeileis A
        Unbiased recursive partitioning: a conditional inference framework.
        J Comput Graph Stat. 2006; 15: 651-674
        • Dima A
        • Allemann S
        • Dediu D
        AdhereR: an open science approach to estimating adherence to medications using electronic healthcare databases.
        Stud Health Technol Inform. 2019; 264: 1451-1452
        • Dima AL
        • Dediu D
        Computation of adherence to medication and visualization of medication histories in R with AdhereR: towards transparent and reproducible use of electronic healthcare data.
        PLoS One. 2017; 12e0174426
        • Sharp RP
        • Sirajuddin R
        • Sharief IM
        Impact of carvedilol on the serum lipid profile.
        Ann Pharmacother. 2008; 42: 564-571
        • Brenner H
        • Gefeller O
        Use of the positive predictive value to correct for disease misclassification in epidemiologic studies.
        Am J Epidemiol. 1993; 138: 1007-1015
        • Sundboll J
        • Adelborg K
        • Munch T
        • Froslev T
        • Sorensen HT
        • Botker HE
        • Schmidt M
        Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study.
        BMJ Open. 2016; 6e012832
        • Sessa M
        • Mascolo A
        • Mortensen RN
        • Andersen MP
        • Rosano GMC
        • Capuano A
        • Rossi F
        • Gislason G
        • Enghusen-Poulsen H
        • Torp-Pedersen C
        Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.
        Eur J Heart Fail. 2018; 20: 548-556
        • Sessa M
        • Mascolo A
        • Scavone C
        • Perone I
        • Giorgio A Di
        • Tari M
        • Fucile A
        • Angelis A De
        • Rasmussen DB
        • Jensen MT
        • Kragholm K
        • Rossi F
        • Capuano A
        • Sportiello L
        Comparison of long-term clinical implications of beta-blockade in patients with obstructive airway diseases exposed to beta-blockers with different beta1-adrenoreceptor selectivity: an Italian population-based cohort study.
        Front Pharmacol. 2018; 9: 1212
        • Hawkins NM
        • Petrie MC
        • Jhund PS
        • Chalmers GW
        • Dunn FG
        • McMurray JJ V
        Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology.
        Eur J Heart Fail. 2009; 11: 130-139
        • William-Olsson T
        • Fellenius E
        • Bjorntorp P
        • Smith U
        Differences in metabolic responses to beta-adrenergic stimulation after propranolol or metoprolol administration.
        Acta Med Scand. 1979; 205: 201-206
        • White JR
        • Campbell RK
        Dangerous and common drug interactions in patients with diabetes mellitus.
        Endocrinol Metab Clin North Am. 2000; 29: 789-802
        • Bakris GL
        • Hart P
        • Ritz E
        Beta blockers in the management of chronic kidney disease.
        Kidney Int. 2006; 70: 1905-1913
        • Takeda T
        • Kohno M
        • Ishii M
        • Kubo S
        • Saruta T
        • Mizuno Y
        • Fukiyama K
        • Fujishima M
        • Yoshimura M
        Efficacy and safety of carvedilol in renal hypertension. A multicenter open trial.
        Eur J Clin Pharmacol. 1990; 38: S158-S163
        • Nowicki M
        • Szewczyk-Seifert G
        • Klimek D
        • Kokot F
        Carvedilol does not modulate moderate exercise-induced hyperkalemia in hemodialysis patients.
        Clin Nephrol. 2002; 57: 352-358
        • Gurbel PA
        • Rout A
        • Bliden K
        • Tantry U
        • Vyas A
        • Chaudhary R
        Comparing carvedilol with metoprolol succinate for all-cause mortality in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis.
        J Am Coll Cardiol. 2019; 73: 1016